According to the authors, these findings support the inclusion of CNV screening in the genetic evaluation of LQTS, particularly in KCNQ1 and KCNH2, as the CNV detection rate in these genes appears to be higher than SNVs in other LQT-related genes [39]. The gene discussed is KCNQ1; the disease is familial long QT syndrome.